Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$16.47
+0.340 (+2.11%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $11.70 $16.59 Friday, 10th May 2024 NVCR stock ended at $16.47. This is 2.11% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.56% from a day low at $16.02 to a day high of $16.59.
90 days $11.70 $18.04
52 weeks $10.87 $83.60

Historical NovoCure Limited prices

Date Open High Low Close Volume
Dec 15, 2023 $13.71 $13.75 $12.96 $13.56 1 744 907
Dec 14, 2023 $13.52 $14.06 $13.50 $13.57 1 448 181
Dec 13, 2023 $12.28 $13.27 $12.10 $13.22 1 936 333
Dec 12, 2023 $12.22 $12.49 $11.66 $12.33 1 597 978
Dec 11, 2023 $12.51 $12.66 $12.19 $12.31 809 270
Dec 08, 2023 $12.85 $12.89 $12.12 $12.50 954 581
Dec 07, 2023 $12.87 $13.06 $12.64 $12.88 1 564 149
Dec 06, 2023 $12.80 $13.30 $12.49 $12.87 1 308 211
Dec 05, 2023 $12.89 $12.90 $12.48 $12.77 1 460 254
Dec 04, 2023 $12.50 $13.37 $12.40 $12.99 1 500 973
Dec 01, 2023 $12.27 $12.55 $11.76 $12.50 1 258 552
Nov 30, 2023 $12.49 $12.49 $12.01 $12.27 1 292 120
Nov 29, 2023 $12.29 $12.79 $12.22 $12.35 1 401 610
Nov 28, 2023 $11.91 $12.36 $11.31 $12.20 1 326 336
Nov 27, 2023 $12.29 $12.34 $11.88 $11.91 1 048 224
Nov 24, 2023 $11.87 $12.75 $11.85 $12.47 641 398
Nov 22, 2023 $12.37 $12.40 $11.85 $11.92 1 074 748
Nov 21, 2023 $12.02 $12.28 $11.58 $12.23 1 582 191
Nov 20, 2023 $12.48 $12.65 $12.15 $12.19 1 229 341
Nov 17, 2023 $11.90 $12.40 $11.63 $12.37 1 801 448
Nov 16, 2023 $12.56 $12.79 $11.79 $11.83 1 166 881
Nov 15, 2023 $12.90 $13.01 $12.57 $12.68 1 354 712
Nov 14, 2023 $11.94 $12.93 $11.92 $12.80 2 513 052
Nov 13, 2023 $11.08 $11.49 $10.87 $11.38 1 286 604
Nov 10, 2023 $11.46 $11.48 $10.95 $11.13 1 308 092
Click to get the best stock tips daily for free!

About NovoCure Limited

NovoCure Limited NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c... NVCR Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT